|
Volumn 57, Issue 7-8, 2009, Pages 509-510
|
The irrepressible rise of biomarkers in oncology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARCINOEMBRYONIC ANTIGEN;
CETUXIMAB;
PANITUMUMAB;
TRASTUZUMAB;
TUMOR MARKER;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER RISK;
CANCER SURGERY;
CHILDHOOD CANCER;
COLORECTAL CANCER;
COLORECTAL SURGERY;
EARLY DIAGNOSIS;
EDITORIAL;
GENOMICS;
HUMAN;
LABORATORY TEST;
LUNG CANCER;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL RESEARCH;
NON INVASIVE PROCEDURE;
ONCOLOGY;
PATIENT MONITORING;
PROGNOSIS;
PROSTATE CANCER;
SINGLE NUCLEOTIDE POLYMORPHISM;
BIOLOGICAL MARKERS;
HUMANS;
MEDICAL ONCOLOGY;
REPRODUCIBILITY OF RESULTS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 71549144789
PISSN: 03698114
EISSN: None
Source Type: Journal
DOI: 10.1016/j.patbio.2008.11.001 Document Type: Editorial |
Times cited : (1)
|
References (7)
|